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ABSTRACT
Background and Objectives: We aimed to investigate whether a large-sized Lasso catheter could increase the success rate 
of immediate complete pulmonary vein (PV) antral isolation and improve the outcome of catheter ablation in atrial fibrilla-
tion (AF) patients. Subjects and Methods: This study included 107 consecutive patients (67 males, mean age: 57.8±9.7 
years) who underwent PV mapping and ablation due to symptomatic drug-refractory AF. The first 43 patients underwent 
isolation of both ipsilateral PVs using the Carto-Merge 3 dimensional mapping system (group 1). The other 64 patients un-
derwent isolation of both ipsilateral PVs using the same technique with a large-sized (a diameter of 30 to 35 mm) Lasso cathe-
ter (group 2). When ipsilateral PVs did not show any potential after the initial circumferential ablation, we defined this as 
‘immediate complete antral isolation (ICAI)’. We compared the AF recurrence rate of both groups. Results: There was no sig-
nificant difference of the clinical characteristics between group 1 and group 2. All the patients were followed-up for 1 year. The 
ICAI rate of group 1 and group 2 was significantly different (21% vs. 78%, p<0.001), and the AF recurrence rates of group 1 
and group 2 were also different (34.9% vs. 18.8%, p=0.042). Using multiple logistic regression analysis, the use of a large-sized 
Lasso catheter was a significant predictive factor for preventing recurrence (odds ratio: 0.489, 95% confidence interval: 0.136-
0.927). Conclusion: It is likely that a large-sized Lasso catheter plays an important role in achieving ICAI and in lowering the 
rate of AF recurrence. (Korean Circ J 2011;41:447-452)
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Introduction
The pulmonary vein (PV) has been the main target for ca-
theter ablation in patients with atrial fibrillation (AF) ever sin-
ce it was identified as the major trigger for AF.
1)2) Different te-
chniques that target the PV include direct trigger ablation,
3) 
segmental ostial PV isolation
4-6) and circumferential PV iso-
lation.
7)8) The first two techniques are seldom used alone cur-
rently because of the high recurrence rate obtained. In cir-
cumferential PV isolation, the endpoint for ablation is the 
electrical disconnection of all PV potentials from the left at-
rium (LA). The PV can be isolated individually or as ipsilat-
eral pairs, the so called ‘en bloc’ isolation, depending on the 
venous anatomy, the catheter stability and the operator’s pre-
ference. In segmental ablation, to monitor complete PV iso-
lation, one or two circular mapping catheters are placed at 
the ostia of the individual PV. This procedure was initially per-
formed under fluoroscopic guidance, but it is now combined 
with a three dimensional (3D) electroanatomic mapping sys-
tem (CARTO or NAVx). To the best of our knowledge, the fe-
asibility and efficacy of using large-sized Lasso catheters, wh-
ich encircle the whole ipsilateral superior and inferior PVs, 
in addition to using a 3D mapping system, have not yet been 
reported. In the present study, we aimed to investigate wheth-
er the large-sized Lasso catheter could affect the clinical out-448   A Large Lasso Catheter in AF Ablation
comes of patients who undergo AF ablation using the Carto 
electroanatomic mapping system.
Subjects and Methods
Study population
This study included 107 consecutive patients (67 males, 
mean age: 57.8±9.7 years) who underwent PV mapping and 
ablation between June 2005 and July 2007. All the patients 
had highly symptomatic, drug refractory paroxysmal or per-
sistent episodes of AF. Patients who received stent placement 
or bypass surgery for significant coronary artery disease were 
excluded. We defined persistent AF as an episode of AF that 
lasted for over 7 days and required cardioversion to restore si-
nus rhythm. All the patients had been on treatment with at 
least one class I or III antiarrhythmic drug and had failed to 
maintain sinus rhythm before ablation. Each patient under-
went transesophageal echocardiography to rule out the pres-
ence of left atrial thrombi before the procedure.
The patients were recruited in a prospective, non-rando-
mized manner. The first 43 patients underwent transseptal 
isolation of both ipsilateral PVs using the 3D electroanatomic 
mapping system (group 1). The remaining 64 patients under-
went isolation of both ipsilateral PVs using the same techni-
que by placing a large-sized (diameter 30-35 mm) circular 
mapping catheter at the pulmonary antrums (group 2). The 
initial 20 cases for each group were excluded to rule out a le-
arning curve effect. Written informed consent for the proce-
dure was obtained from all patients and the study protocol 
was approved by the institutional review board at our medi-
cal center. 
Electrophysiologic study and 3 dimensional 
electroanatomic mapping
A spiral CT scan was obtained prior to the ablation proce-
dure to evaluate the PV anatomy. The patients were given oral 
anticoagulation for at least 2 month before the procedure. 
This oral anticoagulation was discontinued 3 days before the 
procedure to achieve an international normalized ratio of pro-
thrombin time that was less than 2.0. Amiodarone was dis-
continued at least 3 weeks before AF ablation and any other 
antiarrhythmic drugs were suspended for 1 week prior to 
the procedure.
During the procedure, the patient was given intravenous 
sedation with midazolam and fentanyl to achieve an appropri-
ate level of consciousness. Continuous, non-invasive blood 
pressure, heart rate and oxygen saturation monitoring were 
performed throughout the procedure. The surface electro-
grams and bipolar endocardial electrograms were monitored 
and stored on a computer-based digital amplifier/recording 
system (Prucka CardioLab 7000 system, G.E. Medical systems, 
Milwaukee, WI, USA).
Three standard diagnostic catheters were positioned: a 6F 
hexapolar catheter at the His bundle area, a 7F decapolar 
catheter in the right atrium via the left femoral vein and a 7F 
decapolar catheter in the coronary sinus via the right jugular 
vein. A pigtail catheter was introduced into both pulmonary 
arteries via the right femoral vein, and the pulmonary veno-
grams were obtained during the levo phase of both ipsilater-
al pulmonary artery angiographies.
Double transseptal catheterization was performed with an 
8.5F SL1 sheath (St. Jude Medical, Inc., Minnetonka, MN, USA) 
using the Brockenbrough technique. An initial intravenous 
bolus of 5,000 IU heparin was given immediately after the tr-
ansseptal puncture. Repeated doses of heparin were infused 
every 30 minutes to maintain an activated clotting time be-
tween 250 and 350 seconds.
Three-dimensional LA maps were reconstructed using a 
nonfluoroscopic navigation system (Carto XP, Biosense-Web-
ster, Diamond Bar, CA, USA). Electroanatomic mapping was 
performed using an irrigated-tip catheter (Navistar Ther-
mocool, Biosense-Webster, Diamond Bar, CA, USA). The Na-
vistar catheter was placed inside each PV and then it was sl-
owly drawn back to the LA for obtaining multiple PV points. 
Following that, the Navistar explored the entire LA, includ-
ing the anterior wall, the posterior wall, the septal wall, the 
appendage and the mitral annular area. Over 150 points were 
sampled in each procedure. The CT images were transferred 
to the Carto system equipped with the image integration 
software (Carto-Merge
TM Image Integration Module). The Car-
to-Merge software was used to superimpose the reconstruct-
ed 3D CT images on the real time LA electroanatomic map. 
Fig. 1. Three-dimensional mapping of the Carto-Merge on the right 
anterior oblique view. Circumferential ablation around both ipsilat-
eral veins is shown by the red dots.Sung-Won Jang, et al.   449
The merge technique has been previously described.
9) Dur-
ing the AF ablation, we set the fluoroscopy at 6 nGy/p with a 
pulse rate of 10/sec to reduce the radiation exposure.
Ablation procedure
Ablation was performed with the Navistar Thermocool ca-
theter. Radiofrequency energy was applied with a power of 
25 to 35 W and an irrigation rate of 17 to 40 mL/min. Radio-
frequency energy was delivered in each spot for a maximum 
of 40 seconds or until the maximal local electrogram ampli-
tude decreased by 80%. In group 1 patients, we performed 
circumferential antral ablation >5 mm away from the defin-
ed PV ostia after mapping with CartoMerge software (Fig. 1). 
After confirming that there was no anatomical gap on the 3D 
map, a steerable circular catheter with a diameter of either 25 
mm or of variable size (Lasso, Biosense-Webster, Diamond 
Bar, CA, USA) was inserted into each of the PVs (Fig. 2). If the 
Lasso catheter showed no potential or a dissociated potential 
recorded in each PV, then we defined this as “immediate 
complete antral isolation (ICAI)” If the residual conduction 
between the PV and the LA was identified, then additional 
segmental ablation was performed on the previous ablation 
line, as guided by the earliest potentials detected on the st-
andard-sized Lasso catheter. To ablate as close as possible on 
the previous ablation line, we preferred using the variable 
Lasso catheter adjusted to the diameter of the PV antrum. 
For group 2 patients, a large-sized Lasso catheter (30-35 
mm, Biosense-Webster) was placed at the beginning of the 
antral ablation (Fig. 3). This could encircle the entire ipsilater-
al PV in most cases. Circumferential PV isolation was guided 
by the large-sized Lasso catheter as well as the CartoMerge 
electroanatomic mapping. The isolation of each of the PVs 
was verified by putting the standard Lasso catheter (25 mm 
or variable size) into the ipsilateral superior and inferior PVs. 
ICAI was achieved in 78% of the patients. In the remaining pa-
tients, additional antral ablation, guided by a standard Lasso 
catheter, was needed in cases where the large size Lasso cath-
eter did not fit correctly into the ipsilateral PV antrum. 
Fig. 2. Fluoroscopic image confirming the isolation of each pulmonary vein. A variable-sized Lasso catheter was used to verify conduction 
block between the pulmonary vein and the left atrium. Dashed lines are schemes of the ipsilateral pulmonary vein. A: right superior pulmo-
nary vein. B: left superior pulmonary vein. C: right inferior pulmonary vein. D: left inferior pulmonary vein.
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The roof line ablation on the LA
10) was performed in both 
groups after circumferential PV isolation. For patients with 
persistent AF, mitral isthmus ablation was added in both gr-
oups as previously described.
11) The end point of ablation was 
defined as 1) the absence of PV potentials or dissociated PV 
potentials as documented with the standard size (25 mm) or 
variable size Lasso catheters within all four PVs and 2) bidi-
rectional conduction block for the roof line and the mitral 
isthmus line.
Postablation management and follow-up 
After the procedure, anticoagulation with warfarin was re-
started and continued for at least 3 months. Antiarrhythmic 
drugs were reused in 37 (86.0%) and 43 (72.9%) patients in 
group 1 and 2, respectively (p=0.110). Amiodarone was in-
cluded for 9 (24.3%) and 10 (26.3) patients in group 1 and 2, 
respectively (p=0.843). All the patients were monitored by 
ECG during hospitalization. After being discharged, the pa-
tients underwent careful follow-up visits (one week after dis-
charge followed by monthly visits) at the cardiology clinic. On 
each visit, patient symptoms and their surface ECG recordings 
were evaluated. The ambulatory 24-hour ECG monitoring 
was routinely examined at 3, 6 and 12 months, or whenever 
the patient exhibited symptoms. Any documented episode of 
symptomatic or asymptomatic AF that lasted for more than 
30 seconds was considered to be a recurrence. AF recurrence 
within the first 3 months after ablation was not counted as a 
recurrence and those who did not show any evidence of 
tachycardia after 3 months of follow-up were considered as 
successful ablation. All the patients were followed-up for 1 
year. Repeated ablation was not performed during this period.
Statistical analysis
Statistical analysis was performed using Statistical Package 
for the Social Sciences (SPSS) version 12.0 (SPSS Inc., Chicago, 
IL, USA). Continuous variables were expressed as means± 
SDs and they were compared using an unpaired Student’s t-
test. The categorical variables were compared with Fisher’s 
exact test or the χ2 test, where appropriate. All the compari-
sons were two-sided, and p<0.05 were regarded as statistically 
significant. Multiple logistic regression analysis was perform-
ed to identify the independent predictors of AF recurrence. 
Results
Patient and procedural characteristics
The baseline characteristics are summarized in Table 1. Of 
the 107 study subjects, 67 (62.6%) were males (62.6%). The 
number of patients with diabetes and hypertension was 11 
(10.3%) and 41 (38.3%), respectively. There was no signifi-
cant difference for the clinical and procedural characteristics 
between group 1 and group 2. Non-fatal cardiac tamponade 
occurred in 2 patients (one in group 1 and the other in group 
2, p=0.775).
Acute outcomes (immediate complete antral 
isolation)
The rate of successful ICAI showed a significant difference 
between group 1 and 2 (21% vs. 78%, respectively, p<0.001).
Follow-up for atrial fibrillation recurrence
The total AF recurrence rate of group 1 and group 2 was 
34.9% and 18.8%, respectively (Table 2). The recurrence rate 
was not significantly different between group 1 and group 2 
for paroxysmal AF (p=0.210) and persistent AF (p=0.127).
Multiple logistic regression analysis
The variables included in the multivariate analysis were LA 
Fig. 3. Fluoroscopic image in which a large-sized Lasso catheter (35 mm) was used. In group 2 patients, a large-sized Lasso catheter was 
placed at the beginning of the antral ablation. Dashed lines are schemes of ipsilateral pulmonary vein. A: right pulmonary vein. B: left pul-
monary vein.
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size, left ventricular ejection fraction, gender, age, the type of 
AF and the use of a large-sized Lasso catheter. After multiple 
logistic regression analysis, the use of a large-sized Lasso cath-
eter was significant as a predictive factor for preventing recur-
rence (odds ratio: 0.489, 95% confidence interval: 0.136-
0.927). 
Discussion
In this study, we observed that using a large-sized Lasso 
catheter was an independent predictor of freedom from AF 
recurrence after catheter ablation. To our knowledge, this is 
the first report to investigate the feasibility and efficacy of us-
ing a large-sized Lasso catheter in addition to using 3D elec-
troanatomic mapping.
Yamane et al.
12) demonstrated the effectiveness of large-size 
Lasso catheters. The diameter of the Lasso catheter was 25-30 
mm and they used it for antral isolation of individual PVs 
without the 3D mapping system. In contrast, we used a larger 
Lasso (35 mm in diameter) and performed the ‘en bloc’ ab-
lation of the ipsilateral PVs.
PV antral isolation poses a difficulty in achieving a com-
plete conduction block and requires a longer procedure time 
as compared to segmental ostial isolation. However, AF free 
survival was better for antral isolation than for segmental 
ostial isolation.
13)14) Ouyang et al.
7)8) have shown the feasibili-
ty of complete isolation around both ipsilateral PVs in com-
bination with the 3D mapping system and the double-Lasso 
catheter. The reason for using the Lasso catheter in addition 
to the 3D mapping system is that it is easy to directly monitor 
the PV potentials and simultaneously observe conduction 
block when isolating the PV antrum. The limitation of using 
a large-sized Lasso catheter is that occasionally the contact of 
the catheter is not good enough because of the anatomic vari-
ance around the PV antrum. The AF recurrence rate of our 
study was slightly lower than that of a previous study.
7) The 
addition of the roof and mitral isthmus line might have con-
tributed to the lower rate of AF relapse in our study. 
In the present study, the rate of AF recurrence was lower in 
group 2 than in group 1 and the large-sized Lasso catheter 
was a significant predictor for AF recurrence using multivari-
ate analysis. Complete electrical isolation of the PVs has a sig-
nificant impact on the long-term efficacy of the procedure
15) 
and the recovered PV conduction after the AF ablation is a do-
minant factor for AF recurrence.
16) In group 1, only 21% of 
the patients achieved ICAI by 3D-guided antral ablation al-
one and the rest of them needed additional antral ablation 
using the standard Lasso catheter. In contrast, we could ach-
ieve ICAI after initial antral isolation in 78% of the group 2 
patients. In both groups, we tried to deliver radiofrequency 
energy on the previous line as close as possible, but in some 
cases additional ablation should have been performed inside 
the PVs. Although we did not check the PV reconnection in 
the relapsed patients by a redo procedure, we assumed that 
there may be some differences in the recovered PV conduc-
tion between the two groups. Additional linear lesions might 
also have contributed to such ambiguous results. 
Study limitation
First, this study has limitations because of its small sample 
size and non-randomized design. Second, we performed 24-
hour Holter monitoring because 7-day Holter monitoring or 
a transtelephonic recording system was not available. Thus, 
we may have underestimated the asymptomatic recurrence 
of AF. However, this limitation would have equally affected 
both treatment groups. Further investigation will be required 
to determine whether such an approach will have practical 
implications.
Conclusion
The combination method of using the Carto-Merge 3D 
electroanatomic mapping system together with a large sized 
Lasso catheter for AF ablation seem to be more effective than 
3D mapping only for the prevention of AF recurrence. A large 
sized Lasso catheter plays an important role to achieve ICAI. 
Table 1. Baseline and procedural characteristics of the study 
population
Group 1
(n=43)
Group 2
(n=64)
p
Male (%) 58.1 65.6 0.433
Age (years) 56.1±9.4 59.0±9.9 0.129
Paroxysmal AF (%) 58.1 57.8 0.973
Diabetes (%) 09.3 10.9 0.785
Hypertension (%) 49.5 37.5 0.832
Dyslipidemia (%) 09.3 10.9 0.784
Current smoking (%) 16.3 14.1 0.753
LA size (mm) 42.5±4.8 41.8±8.1 0.581
LVEF (%) 62.8±7.4 62.9±7.7 0.951
Antiarrhythmic drugs (%)
Class IC
Amiodarone
Sortalol
37 (86.0)
05 (11.6)
08 (18.6)
51 (79.7)
4 (6.3)
10 (15.6)
0.399
0.326
0.686
Procedure time (minute) 273±74 294±77 0.363
Fluoroscopic time (minute) 192±53 205±75 0.547
Fluoroscopy setting: 6 nGy/p, pulse rate: 10/sec. AF: atrial fibrilla-
tion, LA: left atrium, LVEF: left ventricular ejection fraction
Table 2. Recurrence rate observed in group 1 and group 2
Group 1 (n=43) Group 2 (n=64) p
Paroxysmal AF (%) 28.0 14.7 0.210
Persistent AF (%) 44.4 23.3 0.127
Total (%) 34.9 18.8 0.042
AF: atrial fibrillation452   A Large Lasso Catheter in AF Ablation
The reason for using the Lasso catheter in addition to the 3D 
mapping system is that it is easy to directly monitor the PV 
potentials and simultaneously observe conduction block 
when isolating the PV antrum.
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